Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension
Clinical trial NCT00846989 · COMPLETED
Trial details
- NCT number
- NCT00846989
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-04-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.